Embed

Academic

Authors

Joshua O. Haznedar

Joshua O. Haznedar (Joshua Ö. Haznedar),Pharmacology,Molecular Biology,Toxicology

Edit

Joshua O. Haznedar (Joshua Ö. Haznedar)

Publications: 6 | Citations: 62

Fields: Pharmacology, Molecular Biology, Toxicology

Collaborated with 29 co-authors from 2000 to 2011 | Cited by 206 authors

Cumulative Annual

Sort by:

Publications (6)

BibTeX | RIS | RefWorks Download

1246 LACK OF RG7128 EFFECT ON CARDIAC CONDUCTION IN A THOROUGH QT STUDY

, ,

Journal: Journal of Hepatology - J HEPATOL , vol. 54, pp. S492-S492, 2011

753 IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE (Citations: 1)

, , , , , ,

Journal: Journal of Hepatology - J HEPATOL , vol. 52, pp. S293-S293, 2010

Single and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species (Citations: 6)

, , , , , , , , , ,

Journal: Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL , vol. 64, no. 4, pp. 691-706, 2009

Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits (Citations: 4)

, , , , , , ,

Journal: Birth Defects Research Part B-developmental and Reproductive Toxicology - BIRTH DEFECTS RES PT B , vol. 86, no. 3, pp. 204-213, 2009

Simultaneous determination of SU5416 and its phase I and phase II metabolites in rat and dog plasma by LC/MS/MS (Citations: 2)

, , ,

Journal: Journal of Pharmaceutical and Biomedical Analysis - J PHARMACEUT BIOMED ANAL , vol. 25, no. 5, pp. 821-832, 2001

Sort by:

Citations (62 times by 62 publications)

Phase II study of sunitinib malate in patients with recurrent high-grade glioma (Citations: 4)

, , , , , , , , , ,

Journal: Journal of Neuro-oncology - J NEURO-ONCOL , vol. 103, no. 3, pp. 491-501, 2011

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57412253&selfId1=26654889&selfId2=0&maxNumber=12&query=

Journal: PLOS Pathogens - PLOS PATHOG , vol. 7, no. 11, 2011

PAS domain containing chemoreceptor couples dynamic changes in metabolism with chemotaxis (Citations: 8)

, , ,

Journal: Proceedings of The National Academy of Sciences - PNAS , vol. 107, no. 5, pp. 2235-2240, 2010

Pharmacokinetics of sunitinib malate in subjects with hepatic impairment (Citations: 2)

, , , , ,

Journal: Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL , vol. 66, no. 4, pp. 699-707, 2010

Pharmacology and placental transfer of a human αv integrin monoclonal antibody in rabbits (Citations: 1)

, , , , , , ,

Journal: Birth Defects Research Part B-developmental and Reproductive Toxicology - BIRTH DEFECTS RES PT B , 2010

Comments

Co-authors (29)

Journals (5)

Keywords (16)

Joshua O. Haznedar (Joshua Ö. Haznedar),Pharmacology,Molecular Biology,Toxicology

Publications (6)

BibTeX | RIS | RefWorks Download

1246 LACK OF RG7128 EFFECT ON CARDIAC CONDUCTION IN A THOROUGH QT STUDY

753 IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE (Citations: 1)

Single and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species (Citations: 6)

Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits (Citations: 4)

Simultaneous determination of SU5416 and its phase I and phase II metabolites in rat and dog plasma by LC/MS/MS (Citations: 2)

Citations (62 times by 62 publications)

Phase II study of sunitinib malate in patients with recurrent high-grade glioma (Citations: 4)

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

PAS domain containing chemoreceptor couples dynamic changes in metabolism with chemotaxis (Citations: 8)

Pharmacokinetics of sunitinib malate in subjects with hepatic impairment (Citations: 2)

Pharmacology and placental transfer of a human αv integrin monoclonal antibody in rabbits (Citations: 1)


	View FAQ about top research areas and Fields of study

Co-authors (29)

Journals (5)

Keywords (16)

Joshua O. Haznedar (Joshua Ö. Haznedar),Pharmacology,Molecular Biology,Toxicology

Publications (6) BibTeX | RIS | RefWorks Download

1246 LACK OF RG7128 EFFECT ON CARDIAC CONDUCTION IN A THOROUGH QT STUDY

753 IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE (Citations: 1)

Single and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species (Citations: 6)

Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits (Citations: 4)

Simultaneous determination of SU5416 and its phase I and phase II metabolites in rat and dog plasma by LC/MS/MS (Citations: 2)

Citations (62 times by 62 publications)

Phase II study of sunitinib malate in patients with recurrent high-grade glioma (Citations: 4)

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

PAS domain containing chemoreceptor couples dynamic changes in metabolism with chemotaxis (Citations: 8)

Pharmacokinetics of sunitinib malate in subjects with hepatic impairment (Citations: 2)

Pharmacology and placental transfer of a human αv integrin monoclonal antibody in rabbits (Citations: 1)

Publications (6)

BibTeX | RIS | RefWorks Download